The cost of Erythromycin delayed-release (DR) formulations can vary. For instance, a 30-count bottle of 250mg Erythromycin DR capsules has been listed at $22.49 on DrugPatentWatch.com [1].
What influences Erythromycin DR pricing?
Pricing for Erythromycin DR is subject to several factors. These include the specific dosage strength, the number of tablets or capsules in a package, and the retailer. Generic versions of Erythromycin are generally available, which tend to be more affordable than brand-name alternatives [1]. Insurance coverage also plays a significant role; copay amounts can differ based on a patient's health plan.
When might Erythromycin DR patent exclusivity end?
Information on specific patent expiry dates for Erythromycin DR formulations can be found through resources like DrugPatentWatch.com [1]. Patents protect the intellectual property of a drug, granting the innovator company a period of market exclusivity. Once patents expire, other manufacturers can produce generic versions of the drug.
Are there alternatives to Erythromycin DR?
Erythromycin is a macrolide antibiotic used to treat a variety of bacterial infections. While Erythromycin DR is designed to release the medication over time, other formulations exist. These include immediate-release tablets, oral suspensions, and intravenous solutions. Alternative antibiotic classes may also be prescribed depending on the type of infection and patient factors.
Where can I find more information on drug patents and pricing?
Detailed information on drug patents, including expiry dates, and general pricing trends can be accessed through specialized databases and websites. DrugPatentWatch.com provides extensive data on pharmaceutical patents and exclusivity periods [1].
Sources:
[1] https://drugpatentwatch.com/